Menu
Back to Archived Journals » Core Evidence » Volume 5
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 5, 2010
Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis
Douglas R Jeffery, Emily Poole Pharr
Core Evidence 2010, 5:107-112
Published Date: 8 December 2010
Pitavastatin: evidence for its place in treatment of hypercholesterolemia
Peter Alagona, Jr
Core Evidence 2010, 5:91-105
Published Date: 22 October 2010
Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting
Patrick Langford, Paul Chrisp
Core Evidence 2010, 5:77-90
Published Date: 28 September 2010
Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
Rossana Berardi, Azzurra Onofri, Mirco Pistelli, et al
Core Evidence 2010, 5:61-76
Published Date: 24 September 2010
Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation
Renee M Sullivan, Brian Olshansky
Core Evidence 2010, 5:49-59
Published Date: 15 September 2010
Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review
Sonia Okuyama, Rene Gonzalez, Karl D Lewis
Core Evidence 2010, 5:39-48
Published Date: 1 September 2010
Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
Kristen Kulasa, Steven Edelman
Core Evidence 2010, 5:23-37
Published Date: 13 August 2010
Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis
Eliana Krulig, Kenneth B Gordon
Core Evidence 2010, 5:11-22
Published Date: 5 July 2010
Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson’s disease
Markos Poulopoulos, Cheryl Waters
Core Evidence 2010, 5:1-10
Published Date: 22 December 2009